Condition: Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis · Sponsor: Central Hospital, Nancy, France
Interventional study of a group of patients with an inflammatory bowel disease (IBD; Crohn's disease (CD) or ulcerative colitis (UC)) to identify predictive and prognostic biomarkers of natural history and response to biotherapies.
This description comes directly from the study's public registry record.
Adeline GERMAIN, MD, PhD · +33383153120 · a.germain@chru-nancy.fr
Always discuss trial participation with your own doctor first.
| CHRU Nancy | Vandœuvre-lès-Nancy, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03809728